Ramanathan, Sudarshini
Brilot, Fabienne
Irani, Sarosh R. http://orcid.org/0000-0002-7667-9748
Dale, Russell C. http://orcid.org/0000-0002-2495-1826
Article History
Accepted: 13 January 2023
First Online: 14 February 2023
Competing interests
: S.R. has received research funding from the National Health and Medical Research Council (NHMRC, Australia), the Petre Foundation, the Brain Foundation (Australia), the Royal Australasian College of Physicians, and the University of Sydney. She is supported by an NHMRC Investigator Grant (GNT2008339). She serves as a consultant on an advisory board for UCB and Limbic Neurology, and has been an invited speaker for Biogen, Excemed and Limbic Neurology. F.B. has received research funding from NSW Health, MS Australia, the NHMRC (Australia), the Medical Research Future Fund (Australia) and Novartis. She was on an advisory board for Novartis and Merck, and has been an invited speaker for Biogen, Novartis and Limbic Neurology. S.R.I. is supported by the Wellcome Trust (104079/Z/14/Z) and has received research funding from the UCB–Oxford University Alliance, BMA Research Grants — Vera Down (2013) and Margaret Temple (2017), Fulbright UK-US commission (MS Society research award), and Epilepsy Research UK (P1201). S.R.I. is a co-applicant on ‘Diagnostic Strategy to improve specificity of CASPR2 antibody detection’ (PCT/G82019 /051257) and receives royalties on a licenced patent application WO/210/046716 (PCT/GB2009/051441) entitled Neurological Autoimmune Disorders. S.R.I. has received honoraria from UCB, Immunovant, MedImmun, Roche, Cerebral therapeutics, ADC therapeutics, Brain and Medlink Neurology, and has received research support from CSL Behring, UCB and ONO Pharma. R.C.D. has received research funding from the Star Scientific Foundation, The Trish Multiple Sclerosis Research Foundation, Multiple Sclerosis Research Australia, the Petre Foundation and the NHMRC (Australia; Investigator Grant). He has also received honoraria from Biogen Idec as an invited speaker.